世界の脳腫瘍診断・治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Brain Tumor Diagnosis and Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0978 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、脳腫瘍診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（MRI、CTスキャン、組織サンプリング、PET-CTスキャン、脳動脈造影、腰椎穿刺、分子検査、EEG）、用途別市場規模（手術、放射線療法、化学療法、免疫療法、標的療法）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脳腫瘍診断・治療の市場動向 ・企業の競争状況、市場シェア ・脳腫瘍診断・治療の種類別市場規模（MRI、CTスキャン、組織サンプリング、PET-CTスキャン、脳動脈造影、腰椎穿刺、分子検査、EEG） ・脳腫瘍診断・治療の用途別市場規模（手術、放射線療法、化学療法、免疫療法、標的療法） ・脳腫瘍診断・治療の北米市場規模2016-2027（アメリカ、カナダ） ・脳腫瘍診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳腫瘍診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳腫瘍診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・脳腫瘍診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GE Healthcare、Hitachi、Philips Healthcare、Siemens Healthineers、Toshiba Corporation、Fujifilm Corporation、Shimadzu Corporation、Merck & Co.、AstraZeneca、Bristol Myer Squibb、Novartis、Roche Diagnostics） ・結論

Market Analysis and Insights: Global Brain Tumor Diagnosis and Therapeutics Market
The global Brain Tumor Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Brain Tumor Diagnosis and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Brain Tumor Diagnosis and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Brain Tumor Diagnosis and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Brain Tumor Diagnosis and Therapeutics market.

Global Brain Tumor Diagnosis and Therapeutics Scope and Market Size
Brain Tumor Diagnosis and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Brain Tumor Diagnosis and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
MRI
CT Scan
Tissue Sampling
PET-CT Scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG

Segment by Application
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GE Healthcare
Hitachi
Philips Healthcare
Siemens Healthineers
Toshiba Corporation
Fujifilm Corporation
Shimadzu Corporation
Merck & Co.
AstraZeneca
Siemens Healthineers

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 MRI
1.2.3 CT Scan
1.2.4 Tissue Sampling
1.2.5 PET-CT Scan
1.2.6 Cerebral Arteriogram
1.2.7 Lumbar Puncture
1.2.8 Molecular Testing
1.2.9 EEG
1.3 Market by Application
1.3.1 Global Brain Tumor Diagnosis and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Surgery
1.3.3 Radiation Therapy
1.3.4 Chemotherapy
1.3.5 Immunotherapy
1.3.6 Targeted Therapy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Brain Tumor Diagnosis and Therapeutics Market Perspective (2016-2027)
2.2 Brain Tumor Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Brain Tumor Diagnosis and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Brain Tumor Diagnosis and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Brain Tumor Diagnosis and Therapeutics Industry Dynamic
2.3.1 Brain Tumor Diagnosis and Therapeutics Market Trends
2.3.2 Brain Tumor Diagnosis and Therapeutics Market Drivers
2.3.3 Brain Tumor Diagnosis and Therapeutics Market Challenges
2.3.4 Brain Tumor Diagnosis and Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue
3.1.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Brain Tumor Diagnosis and Therapeutics Revenue
3.4 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio
3.4.1 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnosis and Therapeutics Revenue in 2020
3.5 Brain Tumor Diagnosis and Therapeutics Key Players Head office and Area Served
3.6 Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
3.7 Date of Enter into Brain Tumor Diagnosis and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Type
4.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027)

5 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Application
5.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Brain Tumor Diagnosis and Therapeutics Market Size (2016-2027)
6.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type
6.2.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2027)
6.3 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application
6.3.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2027)
6.4 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country
6.4.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size (2016-2027)
7.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type
7.2.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application
7.3.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country
7.4.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size (2016-2027)
9.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type
9.2.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application
9.3.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country
9.4.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Introduction
11.1.4 GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.1.5 GE Healthcare Recent Development
11.2 Hitachi
11.2.1 Hitachi Company Details
11.2.2 Hitachi Business Overview
11.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Introduction
11.2.4 Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.2.5 Hitachi Recent Development
11.3 Philips Healthcare
11.3.1 Philips Healthcare Company Details
11.3.2 Philips Healthcare Business Overview
11.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Introduction
11.3.4 Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.3.5 Philips Healthcare Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Introduction
11.4.4 Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.4.5 Siemens Healthineers Recent Development
11.5 Toshiba Corporation
11.5.1 Toshiba Corporation Company Details
11.5.2 Toshiba Corporation Business Overview
11.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Introduction
11.5.4 Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.5.5 Toshiba Corporation Recent Development
11.6 Fujifilm Corporation
11.6.1 Fujifilm Corporation Company Details
11.6.2 Fujifilm Corporation Business Overview
11.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Introduction
11.6.4 Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.6.5 Fujifilm Corporation Recent Development
11.7 Shimadzu Corporation
11.7.1 Shimadzu Corporation Company Details
11.7.2 Shimadzu Corporation Business Overview
11.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Introduction
11.7.4 Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.7.5 Shimadzu Corporation Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Details
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Introduction
11.8.4 Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.8.5 Merck & Co. Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Introduction
11.9.4 AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Bristol Myer Squibb
11.10.1 Bristol Myer Squibb Company Details
11.10.2 Bristol Myer Squibb Business Overview
11.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Introduction
11.10.4 Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.10.5 Bristol Myer Squibb Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Introduction
11.11.4 Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.11.5 Novartis Recent Development
11.12 Roche Diagnostics
11.12.1 Roche Diagnostics Company Details
11.12.2 Roche Diagnostics Business Overview
11.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Introduction
11.12.4 Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
11.12.5 Roche Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of MRI
Table 3. Key Players of CT Scan
Table 4. Key Players of Tissue Sampling
Table 5. Key Players of PET-CT Scan
Table 6. Key Players of Cerebral Arteriogram
Table 7. Key Players of Lumbar Puncture
Table 8. Key Players of Molecular Testing
Table 9. Key Players of EEG
Table 10. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Brain Tumor Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Brain Tumor Diagnosis and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Brain Tumor Diagnosis and Therapeutics Market Share by Regions (2016-2021)
Table 14. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Brain Tumor Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Table 16. Brain Tumor Diagnosis and Therapeutics Market Trends
Table 17. Brain Tumor Diagnosis and Therapeutics Market Drivers
Table 18. Brain Tumor Diagnosis and Therapeutics Market Challenges
Table 19. Brain Tumor Diagnosis and Therapeutics Market Restraints
Table 20. Global Brain Tumor Diagnosis and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players (2016-2021)
Table 22. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2020)
Table 23. Ranking of Global Top Brain Tumor Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
Table 27. Date of Enter into Brain Tumor Diagnosis and Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Table 31. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Brain Tumor Diagnosis and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2016-2021)
Table 35. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 67. GE Healthcare Company Details
Table 68. GE Healthcare Business Overview
Table 69. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product
Table 70. GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 71. GE Healthcare Recent Development
Table 72. Hitachi Company Details
Table 73. Hitachi Business Overview
Table 74. Hitachi Brain Tumor Diagnosis and Therapeutics Product
Table 75. Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Hitachi Recent Development
Table 77. Philips Healthcare Company Details
Table 78. Philips Healthcare Business Overview
Table 79. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product
Table 80. Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Philips Healthcare Recent Development
Table 82. Siemens Healthineers Company Details
Table 83. Siemens Healthineers Business Overview
Table 84. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product
Table 85. Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Siemens Healthineers Recent Development
Table 87. Toshiba Corporation Company Details
Table 88. Toshiba Corporation Business Overview
Table 89. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product
Table 90. Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Toshiba Corporation Recent Development
Table 92. Fujifilm Corporation Company Details
Table 93. Fujifilm Corporation Business Overview
Table 94. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product
Table 95. Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Fujifilm Corporation Recent Development
Table 97. Shimadzu Corporation Company Details
Table 98. Shimadzu Corporation Business Overview
Table 99. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product
Table 100. Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Shimadzu Corporation Recent Development
Table 102. Merck & Co. Company Details
Table 103. Merck & Co. Business Overview
Table 104. Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Merck & Co. Recent Development
Table 106. AstraZeneca Company Details
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product
Table 109. AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 110. AstraZeneca Recent Development
Table 111. Bristol Myer Squibb Company Details
Table 112. Bristol Myer Squibb Business Overview
Table 113. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product
Table 114. Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Bristol Myer Squibb Recent Development
Table 116. Novartis Company Details
Table 117. Novartis Business Overview
Table 118. Novartis Brain Tumor Diagnosis and Therapeutics Product
Table 119. Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Novartis Recent Development
Table 121. Roche Diagnostics Company Details
Table 122. Roche Diagnostics Business Overview
Table 123. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product
Table 124. Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 125. Roche Diagnostics Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Tumor Diagnosis and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. MRI Features
Figure 3. CT Scan Features
Figure 4. Tissue Sampling Features
Figure 5. PET-CT Scan Features
Figure 6. Cerebral Arteriogram Features
Figure 7. Lumbar Puncture Features
Figure 8. Molecular Testing Features
Figure 9. EEG Features
Figure 10. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application: 2020 VS 2027
Figure 11. Surgery Case Studies
Figure 12. Radiation Therapy Case Studies
Figure 13. Chemotherapy Case Studies
Figure 14. Immunotherapy Case Studies
Figure 15. Targeted Therapy Case Studies
Figure 16. Brain Tumor Diagnosis and Therapeutics Report Years Considered
Figure 17. Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Brain Tumor Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 20. Global Brain Tumor Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Figure 21. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players in 2020
Figure 22. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue in 2020
Figure 24. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 25. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 26. North America Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Brain Tumor Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 28. North America Brain Tumor Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 29. North America Brain Tumor Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 30. United States Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Brain Tumor Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 34. Europe Brain Tumor Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 35. Europe Brain Tumor Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 36. Germany Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Share by Region (2016-2027)
Figure 46. China Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 54. Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 55. Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 56. Mexico Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 62. Turkey Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. GE Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 66. Hitachi Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 67. Philips Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 68. Siemens Healthineers Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 69. Toshiba Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 70. Fujifilm Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 71. Shimadzu Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 72. Merck & Co. Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 73. AstraZeneca Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 74. Bristol Myer Squibb Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 75. Novartis Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 76. Roche Diagnostics Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---